Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Juan Ignacio Jorquera"'
Autor:
Maria Isabel Bravo, Alba Pérez, Aida Raventós, Salvador Grancha, Juan Ignacio Jorquera, Nora Viviana Butta, Maria Teresa Álvarez‐Román, Montserrat Costa, Todd Willis, Victor Jiménez‐Yuste
Publikováno v:
Haemophilia. 28:737-744
Presence of von Willebrand factor (VWF) in FVIII concentrates offers protection against neutralizing inhibitors in haemophilia A (HA). Whether this protection is more evident in plasma-derived (pd) FVIII/VWF or recombinant (r) FVIII concentrates rema
Autor:
Ana Maria Ortiz, Giuseppe Melacini, Montserrat Costa, Juan Ignacio Jorquera, Julijana Milojevic
Publikováno v:
Journal of Alzheimer's disease : JAD. 38(4)
Background A promising approach for treating Alzheimer's disease relies on the net efflux of the amyloid-β (Aβ) peptide from the brain to peripheral plasma, as a result of plasma Aβ clearance promoted by plasma removal and therapeutic albumin repl
Publikováno v:
Alzheimer's & Dementia. 9
Publikováno v:
Thrombosis Research. 82:217-224
APC resistance appears to be caused, predominantly, by a mutation in coagulation factor V (nucleotide 1691: G to A). This phenomenon is usually studied by performing APTTs in the absence and presence of added APC. We studied a modification of the ass
Autor:
B. Kemkes-Matthes, B. Schlott, S. Huraib, Isa Francalanci, K.J. Matthes, Pilar Casaña, E. Lafoz, C. Biosca, Akikazu Takada, Agatina Alessandrello Liotta, Francisco Martínez, Domenico Prisco, J. Al-Wakeel, N. Memon, M. Hartmann, H. Abu-Aisha, Nicoletta Zarone, Lorenzo Ji, Manuel Monreal, Rosanna Abbate, A.M.A. Gader, J. Hauptmann, José A. Páramo, G.L. Bergonzini, Pietro Bianchini, José A. Aznar, Eduardo Rocha, A.K. Al-Momen, B. Parma, J. Quiroga, K.-H. Gührs, B. Osima, Yumiko Takada, A. Corominas, B. Sangro, Tetsumei Urano, R. Galimany, Paolo Comeglio, Jolanta Malyszko, Sandra Fedi, A. Urrutia, Javier Roncales, Anna Paola Cellai, José Rifón, Felipe Prosper, Juan Ignacio Jorquera
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 25:I-V
Publikováno v:
Alzheimer's & Dementia. 8
Publikováno v:
Journal of Alzheimer's disease : JAD. 29(1)
Clearance of plasma amyloid-β (Aβ) through plasma exchange and replacement with therapeutic albumin to facilitate net Aβ efflux from the brain to plasma is a novel approach for the treatment of Alzheimer's disease. Therefore, thorough characteriza
Publikováno v:
Alzheimer's & Dementia. 7
Publikováno v:
Revista de neurologia. 50
Most plasma beta-amyloid peptide (Alphabeta) has been described to circulate bound to albumin (approx. 90%). Moreover, a balance between peripheral and brain Alphabeta seems to exist, so a reduction of Alphabeta levels in blood through plasma exchang